Markers of inflammation and bone remodelling associated with improvement in clinical response measures in psoriatic arthritis patients treated with golimumab

OBJECTIVE: To determine serum biomarker associations with clinical response to golimumab treatment in patients with psoriatic arthritis (PsA). METHODS: GO–REVEAL was a randomised, placebo-controlled study of golimumab in patients with active PsA. Samples were collected from 100 patients at baseline,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Carrie L, Visvanathan, Sudha, Elashoff, Michael, McInnes, Iain B, Mease, Philip J, Krueger, Gerald G, Murphy, Frederick T, Papp, Kim, Gomez-Reino, Juan J, Mack, Michael, Beutler, Anna, Gladman, Dafna, Kavanaugh, Arthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551220/
https://www.ncbi.nlm.nih.gov/pubmed/22975755
http://dx.doi.org/10.1136/annrheumdis-2012-201697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551220/
https://www.ncbi.nlm.nih.gov/pubmed/22975755
http://dx.doi.org/10.1136/annrheumdis-2012-201697

Ejemplares similares